A trial in St. Louis involving a plaintiff who alleges exposure to Roundup caused her non-Hodgkin lymphoma has been delayed indefinitely, leading to speculation that Bayer and plaintiffs’ lawyers need the time to work out a settlement.
With an eye on the future of agriculture and the need to address shareholders and customers expectations, Bayer confirmed an ambitious plan to address climate change and a more sustainable farming future during events in Monheim, Germany, this week.
Pro- and anti-glyphosate companies and organizations lined up to praise — or bash — the active ingredient in the most widely applied herbicide in the world, in comments submitted to the Environmental Protection Agency last week.
A California state court judge has significantly reduced damages awarded to a couple whose non-Hodgkin lymphoma was blamed on Roundup exposure, cutting their overall award from more than $2 billion to $86.7 million.
Despite some harsh words describing Monsanto’s conduct, a federal judge said last week he plans to reduce an $80 million award to a California man who claimed exposure to Roundup caused his non-Hodgkin lymphoma.
Glyphosate registrants defended their products as safe to use in comments submitted this week to the Agency for Toxic Substances and Disease Registry, which issued a report in April saying it could not “rule out” an association between exposure to glyphosate-based products and the risk of cancer.